Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Acadia Pharmaceutica (NQ: ACAD ) 15.30 +0.13 (+0.86%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Acadia Pharmaceutica < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 6, 2024 October 17, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals Announces Health Canada Approval of DAYBUE™ (trofinetide) for the Treatment of Rett Syndrome October 16, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Critical Insights From ACADIA Pharmaceuticals Analyst Ratings: What You Need To Know October 10, 2024 Via Benzinga Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 08, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Expert Outlook: ACADIA Pharmaceuticals Through The Eyes Of 5 Analysts August 07, 2024 Via Benzinga A Closer Look at 13 Analyst Recommendations For ACADIA Pharmaceuticals July 12, 2024 Via Benzinga Expert Ratings For ACADIA Pharmaceuticals June 25, 2024 Via Benzinga Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 26, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire What's Going On With ACADIA Pharmaceuticals Stock? September 24, 2024 ACADIA Pharmaceuticals shares are trading lower by 4.6% during Tuesday's session. The company appointed Catherine Owen Adams as CEO. Via Benzinga Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals September 23, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences August 28, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Jim Cramer Believes In Dell CEO, Doesn't Like B&G Foods August 27, 2024 Cramer gives his take on E.l.f Beauty, Acadia Pharmaceuticals, B&G Foods, Lucid, SoFi, Dell, Johnson & Johnson, UWM and Symbotic. Via Benzinga Ryan Reynolds Announces More to Parkinson’s® Campaign August 14, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals to Participate in the Canaccord Genuity 44th Annual Growth Conference August 07, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains' August 07, 2024 Acadia led a biotech selloff on Wednesday as Daybue sales missed expectations. Via Investor's Business Daily Topics Earnings Exposures Financial Airbnb Reports Weak Earnings, Joins Cryoport, Tripadvisor, Lyft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session August 07, 2024 Via Benzinga Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview August 06, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2024 July 24, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med July 18, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday June 27, 2024 Via Benzinga Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting June 18, 2024 From Acadia Pharmaceuticals, Inc. Via Business Wire 3 Sorry Pharma Stocks to Sell in May While You Still Can May 29, 2024 Discover three pharma stocks to sell in May while you still can. Avoid these companies facing significant setbacks. Via InvestorPlace After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February May 24, 2024 Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications. Via Benzinga Topics Data Breach Exposures Information Security Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 17, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome May 15, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar May 09, 2024 Under-the-radar penny stocks can be some of the most rewarding investments on the market. Here are three to consider. Via InvestorPlace Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences May 09, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire ACAD Stock Earnings: ACADIA Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024 May 08, 2024 ACAD stock results show that ACADIA Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview May 08, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire ACADIA Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (25 Ratings) April 30, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.